Site Search
Results
-
TR-578: Ginkgo Biloba Extract (CASRN 90045-36-6) in F344/N Rats...
... cases of spontaneous bleeding associated with Ginkgo biloba extract through 2007, with one third of the cases involving concurrent use of antiplatelet or anticoagulant therapies. ...
Size: 4.1MB https://ntp.niehs.nih.gov/go/tr578 -
ICCVAM Biennial Progress Report 2020-2021
... and adoption of human MPS for testing therapies and improving disease understanding. ... to apply MPS to the development of therapies for COVID-19. Activities of the MPSCoRe ...
Size: 940KB https://ntp.niehs.nih.gov/iccvamreport/2021 -
RoC Background Document: Chlorozotocin (CZT); Nov. 18-19, 1996
... relative risk, 12.4; 95% confidence interval, 1.7- 250) among 2067 patients treated with methyl-CCNU. Only 1 case was observed among 1566 patients treated with other therapies. ...
Size: 1.6MB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/other_background/chlorozotocin1_508be.pdf -
RoC Background Document: Chloramphenicol; Dec. 13-14, 2000
... transplantation and immunosuppressive therapies, has improved the prognosis for these 11 ... Although it is possible that certain therapies may contribute to the development of MDS/...
Size: 751KB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/roc10/chl_no_appendices_508.pdf -
Public Comment on 81 FR 42718: C. Elegans Models for Developmental...
... CMR (1999). c Includes anti-inflammatory therapies. 66 OLSON ET AL. vance for Man (C. E. Lumley and S. W. Walker, Eds.), pp. 15-19. Quay, Lancaster, UK. Calabrese, E. J. (1984). ...
Size: 2.0MB https://ntp.niehs.nih.gov/iccvam/pubcomment/fr-2016-15444/hunt-81fr42718.pdf -
NTP-CERHR Monograph: Potential Human Reproductive and Developmental...
... - should override any theoretical or unproven risk associated with medical therapies. ... on the most commonly used device categories, therapies, and certain disease conditions. ...
Size: 5.6MB https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/phthalates/dbp/dbp_monograph_final.pdf -
NTP-CERHR Monograph: Potential Human Reproductive and Developmental...
... ECMO.patients,.cardiopulmonary. by-pass.patients,.infants,.and.chil- dren.receiving.exchange.transfu- sions,. patients. receiving. some. IV. therapies. such. as.TPN. and. ...
Size: 3.0MB https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/phthalates/dehp/dehp-monograph.pdf -
RoC Background Document: Ultraviolet (UV) Radiation, Broad Spectrum...
... and 1984 and treated with different UVR therapies (30 cases and 137 controls for ... such as sunlamps and sunbeds, medical therapies, fluorescent lighting, and welding. ...
Size: 3.0MB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/roc10/uv_no_appendices_508.pdf -
CERHR Monograph: Potential Human Reproductive and Developmental...
... Currently, the information is inadequate to predict adverse reactions or determine appropriate therapies for fetuses, neonates, infants, and children. Table 19. Ontogeny of Human ...
Size: 4.8MB https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/acrylamide/acrylamide_monograph.pdf -
GMM-14: Genetically Modified Model Report on 3'-Azido-3'-Deoxythymidin...
... Pluda, J.M., Mitsuya, H., and Yarchoan, R. (1991). Hematologic effects of AIDS therapies. Hematol. Oncol. Clin. North Am. 5, 229-248. 62 3'-Azido-3'-Deoxythymidine, NTP GMM 14 ...
Size: 3.2MB https://ntp.niehs.nih.gov/go/gmm14
to Top